Brief: Astrazeneca Pharma India Enters Distribution Agreement With Abbott Healthcare

Abbott India

07/12/2018 06:43

Dec 7 (Reuters) - Astrazeneca Pharma India Ltd  ASTR.NS :
    * SAYS ENTERED INTO A DISTRIBUTION AGREEMENT FOR
DISTRIBUTION OF
DAPAGLIFLOZIN
    * SAYS UNDER AGREEMENT, ABBOTT WILL PROMOTE AND DISTRIBUTE
DAPAGLIFLOZIN UNDER BRAND NAME GLEDEPA
    * ABBOTT WILL ALSO GAIN RIGHTS TO PROMOTE, DISTRIBUTE
COMBINATION
OF DAPAGLIFLOZIN WITH METFORMIN UNDER BRAND NAME GLEDEPA MET

Source text: http://bit.ly/2BVLZO1
Further company coverage:  ASTR.NS 

 ((Reuters.Briefs@thomsonreuters.com;))